| # | Drug | Count |
|---|---|---|
| 0 | CLONAZEPAM | 3 |
| 1 | PHENYTOIN | 3 |
| 2 | PREDNISONE | 3 |
| 3 | ATORVASTATIN CALCIUM | 2 |
| 4 | AZATHIOPRINE | 2 |
| 5 | CITALOPRAM | 2 |
| 6 | CYCLOPHOSPHAMIDE | 2 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 9 | DANAZOL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROCHLORPERAZINE EDISYLATE | 1 | 0.0008 |
| 1 | DANAZOL | 2 | 0.0007 |
| 2 | DOXYCYCLINE MONOHYDRATE | 1 | 0.0006 |
| 3 | GALANTAMINE HYDROBROMIDE | 1 | 0.0006 |
| 4 | ISOFLURANE | 1 | 0.0005 |
| 5 | DEXMEDETOMIDINE | 1 | 0.0003 |
| 6 | BECLOMETHASONE DIPROPIONATE | 1 | 0.0002 |
| 7 | INCOBOTULINUMTOXINA | 1 | 0.0002 |
| 8 | ALISKIREN HEMIFUMARATE | 1 | 0.0002 |
| 9 | PHENYTOIN | 3 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 8 |
| 1 | Benzodiazepine [EPC] | 5 |
| 2 | Anti-epileptic Agent [EPC] | 3 |
| 3 | Azole Antifungal [EPC] | 3 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 3 |
| 5 | Alkylating Drug [EPC] | 2 |
| 6 | Androgen [EPC] | 2 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 2 |
| 8 | Complement Inhibitor [EPC] | 2 |
| 9 | Integrin Receptor Antagonist [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Barbiturate [EPC] | 1 | 0.0001 |
| 1 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Androgen [EPC] | 2 | 0.0001 |
| 3 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 5 | Complement Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |
| 7 | General Anesthetic [EPC] | 1 | 0.0000 |
| 8 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Purine Antimetabolite [EPC] | 2 | 0.0000 |